Pure Global

Clinical Trial - Trial ChiCTR2100049104

Access comprehensive clinical trial information for ChiCTR2100049104 through Pure Global AI's free database. This Phase 3 trial is sponsored by Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region and is currently Not yet recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100049104
Phase 3
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100049104
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
A Global, Multi center, Randomized, Double Blind, Placebo controlled, Phase III Clinical Study to Evaluate the Protective Efficacy, Safety and Immunogenicity of Novel Coronavirus (mRNA) Vaccine in Population Aged 18 Years and Older

Study Focus

Sponsor & Location

Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region

Self financed

China

Timeline & Enrollment

Phase 3

N/A

Mar 31, 2023

ICD-10 Classifications

COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere

Data Source

Chinese Clinical Trial Registry

ChiCTR2100049104

Non-Device Trial